Cargando…
Improved EGFR mutation detection using combined exosomal RNA and circulating tumor DNA in NSCLC patient plasma
BACKGROUND: A major limitation of circulating tumor DNA (ctDNA) for somatic mutation detection has been the low level of ctDNA found in a subset of cancer patients. We investigated whether using a combined isolation of exosomal RNA (exoRNA) and cell-free DNA (cfDNA) could improve blood-based liquid...
Autores principales: | Krug, A K, Enderle, D, Karlovich, C, Priewasser, T, Bentink, S, Spiel, A, Brinkmann, K, Emenegger, J, Grimm, D G, Castellanos-Rizaldos, E, Goldman, J W, Sequist, L V, Soria, J -C, Camidge, D R, Gadgeel, S M, Wakelee, H A, Raponi, M, Noerholm, M, Skog, J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5889041/ https://www.ncbi.nlm.nih.gov/pubmed/29216356 http://dx.doi.org/10.1093/annonc/mdx765 |
Ejemplares similares
-
Exosome-based detection of activating and resistance EGFR mutations from plasma of non-small cell lung cancer patients
por: Castellanos-Rizaldos, Elena, et al.
Publicado: (2019) -
Exosome-based liquid biopsies in cancer: opportunities and challenges
por: Yu, W., et al.
Publicado: (2021) -
Characterization of RNA from Exosomes and Other Extracellular Vesicles Isolated by a Novel Spin Column-Based Method
por: Enderle, Daniel, et al.
Publicado: (2015) -
Validation of a CE-IVD, urine exosomal RNA expression assay for risk assessment of prostate cancer prior to biopsy
por: Kretschmer, Alexander, et al.
Publicado: (2022) -
Extracellular vesicles from plasma have higher tumour RNA fraction than platelets
por: Brinkman, Kay, et al.
Publicado: (2020)